At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Supplements to Improve Vascular Inflammation After an Adverse Pregnancy Outcome
In Brief
A clinical study evaluating Anti-inflammatory supplement for Pre-Eclampsia and 3 related conditions. Completed, enrolled 9 participants across 1 site.
Detailed Summary
Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the past 3 years to receive an anti-inflammatory supplement or serve as a time control. Investigators will compare blood pressure, arterial stiffness, blood vessel reactivity, and blood markers of inflammation between women who did and did not receive the supplement. Investigators will determine women's attitudes about taking a dietary supplement and measure whether the participants who receive the supplement take all or most of the doses.
Study Details
Timeline
Interventions
commercially available combination of curcumin, quercitin, resveratrol, and green tea